stella
beta
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years — Stella
Recruiting
Back to Tuberculosis trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Indonesia
Rumah Sakit Islam Jakarta Cempaka Putih, Jakarta
View full record on ClinicalTrials.gov